ALLMedicine™ Vulvar Cancer Center
Research & Reviews 1,071 results
https://doi.org/10.1016/j.ygyno.2021.02.005
Gynecologic Oncology; Bohlin KS, Bruno AK et. al.
Feb 23rd, 2021 - To investigate the impact of a preoperative CT on surgical decision making in primary vulvar squamous cell carcinoma (VSCC) and the accuracy of detecting inguinal lymph node metastases (LNM). Secondly to assess prevalence and consequences of incid...
https://doi.org/10.1007/s00259-021-05257-8 10.1016/S0020-7292(12)60021-6 10.1016/0090-8258(83)90092-6 10.1016/j.ygyno.2006.03.022 10.3802/jgo.2016.27.e60 10.1006/gyno.1995.1151 10.1002/micr.30142 10.1016/j.ygyno.2013.07.103 10.1002/uog.20378 10.1002/cncy.22154 10.1007/s00330-014-3530-1 10.1006/gyno.2002.6605 10.1007/s00404-015-3927-3 10.1016/j.ygyno.2016.01.011 10.1016/j.ejso.2017.06.018 10.1097/MD.0000000000007943 10.2967/jnumed.117.194332 10.4103/wjnm.WJNM_32_17 10.2967/jnumed.118.215889 10.1097/RLU.0000000000003411 10.1016/j.ijgo.2009.02.011 10.1007/s00259-014-2961-x 10.1007/s00259-015-3128-0 10.1097/IGC.0000000000000975 10.1016/j.jbi.2014.02.013 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 10.1007/s00259-019-04650-8 10.1016/j.gynor.2012.12.009 10.1136/ijgc-2020-001363 10.1148/radiol.2212010280 10.6004/jnccn.2019.7288
European Journal of Nuclear Medicine and Molecular Imaging; Rufini V, Garganese G et. al.
Feb 23rd, 2021 - This retrospective study aimed to assess the diagnostic performance of preoperative [18F]FDG-PET/CT in predicting the groin and pelvic lymph node (LN) status in a large single-centre series of vulvar cancer patients. Between January 2013 and Octob...
https://doi.org/10.1016/j.ygyno.2021.01.031
Gynecologic Oncology; Koual M, Benoit L et. al.
Feb 8th, 2021 - Sentinel lymph node biopsy (SLN) helps define lymph node status, a major prognostic factor in vulvar cancer. The aim of the current systematic review was to assess the use of indocyanine green (ICG) coupled with near-infrared (NIR) fluorescence im...
https://doi.org/10.1016/j.ygyno.2021.01.003
Gynecologic Oncology; Ashmore S, Crafton SM et. al.
Jan 27th, 2021 - The optimal overall treatment time (OTT) from radical surgery to the end of adjuvant radiation therapy for some squamous cell carcinomas has been found to impact treatment outcomes. This study aims to identify the impact of OTT on overall survival...
https://doi.org/10.3802/jgo.2021.32.e24
Journal of Gynecologic Oncology; Matsuo K, Nishio S et. al.
Jan 20th, 2021 - Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study.|2021|Matsuo K,Nishio S,Matsuzaki S,Machida H,Mikami M,|
Guidelines 7 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882649
International Journal of Clinical Oncology; Saito T, Tabata T et. al.
Nov 21st, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...
https://doi.org/10.1097/IGC.0000000000000975
International Journal of Gynecological Cancer : Official ... Oonk MHM, Planchamp F et. al.
Apr 25th, 2017 - The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe. The European S...
https://doi.org/10.6004/jnccn.2017.0008
Journal of the National Comprehensive Cancer Network : JN... Koh WJ, Greer BE et. al.
Jan 3rd, 2017 - Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)-dependent and HPV-independent pathways. The NCCN Vulvar Cancer ...
http://www.jnccn.org/content/15/1/92.full
Koh, W.,et al
Dec 31st, 2016 - Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)–dependent and HPV-independent pathways.
https://doi.org/10.6004/jnccn.2016.0184
Journal of the National Comprehensive Cancer Network : JN... Greer BE, Koh WJ
May 26th, 2016 - For the first time, NCCN Guidelines are available for vulvar cancer, a rare gynecologic cancer. Early-stage cancers can be managed by surgery and observation, and many of these patients can be cured. Lymph node status drives treatment and correlat...
Clinicaltrials.gov 1,113 results
https://doi.org/10.1016/j.ygyno.2021.02.005
Gynecologic Oncology; Bohlin KS, Bruno AK et. al.
Feb 23rd, 2021 - To investigate the impact of a preoperative CT on surgical decision making in primary vulvar squamous cell carcinoma (VSCC) and the accuracy of detecting inguinal lymph node metastases (LNM). Secondly to assess prevalence and consequences of incid...
https://doi.org/10.1007/s00259-021-05257-8 10.1016/S0020-7292(12)60021-6 10.1016/0090-8258(83)90092-6 10.1016/j.ygyno.2006.03.022 10.3802/jgo.2016.27.e60 10.1006/gyno.1995.1151 10.1002/micr.30142 10.1016/j.ygyno.2013.07.103 10.1002/uog.20378 10.1002/cncy.22154 10.1007/s00330-014-3530-1 10.1006/gyno.2002.6605 10.1007/s00404-015-3927-3 10.1016/j.ygyno.2016.01.011 10.1016/j.ejso.2017.06.018 10.1097/MD.0000000000007943 10.2967/jnumed.117.194332 10.4103/wjnm.WJNM_32_17 10.2967/jnumed.118.215889 10.1097/RLU.0000000000003411 10.1016/j.ijgo.2009.02.011 10.1007/s00259-014-2961-x 10.1007/s00259-015-3128-0 10.1097/IGC.0000000000000975 10.1016/j.jbi.2014.02.013 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 10.1007/s00259-019-04650-8 10.1016/j.gynor.2012.12.009 10.1136/ijgc-2020-001363 10.1148/radiol.2212010280 10.6004/jnccn.2019.7288
European Journal of Nuclear Medicine and Molecular Imaging; Rufini V, Garganese G et. al.
Feb 23rd, 2021 - This retrospective study aimed to assess the diagnostic performance of preoperative [18F]FDG-PET/CT in predicting the groin and pelvic lymph node (LN) status in a large single-centre series of vulvar cancer patients. Between January 2013 and Octob...
https://doi.org/10.1016/j.ygyno.2021.01.031
Gynecologic Oncology; Koual M, Benoit L et. al.
Feb 8th, 2021 - Sentinel lymph node biopsy (SLN) helps define lymph node status, a major prognostic factor in vulvar cancer. The aim of the current systematic review was to assess the use of indocyanine green (ICG) coupled with near-infrared (NIR) fluorescence im...
https://doi.org/10.1016/j.ygyno.2021.01.003
Gynecologic Oncology; Ashmore S, Crafton SM et. al.
Jan 27th, 2021 - The optimal overall treatment time (OTT) from radical surgery to the end of adjuvant radiation therapy for some squamous cell carcinomas has been found to impact treatment outcomes. This study aims to identify the impact of OTT on overall survival...
https://doi.org/10.3802/jgo.2021.32.e24
Journal of Gynecologic Oncology; Matsuo K, Nishio S et. al.
Jan 20th, 2021 - Hospital volume-outcome relationship in vulvar cancer treatment: a Japanese Gynecologic Oncology Group study.|2021|Matsuo K,Nishio S,Matsuzaki S,Machida H,Mikami M,|
News 29 results
https://www.mdedge.com/hematology-oncology/article/219514/coronavirus-updates/how-long-it-safe-delay-gynecologic-cancer/page/0/1?channel=64518
Mar 24th, 2020 - Lower genital tract cancers Dr. Emma C.
https://www.mdedge.com/familymedicine/article/164419/gynecologic-cancer/leg-lymphedema-after-gynecologic-lymphadenectomy
MDedge ObGyn; Mitchel L. Zoler
Apr 27th, 2018 - NEW ORLEANS – Leg lymphedema occurred in 19%-40% of women with a gynecologic cancer who underwent surgery with lymphadenectomy in a prospective study of 821 U. S.
https://www.mdedge.com/node/145629/path_term/49726
Sep 1st, 2017 - “THE PELVIC EXAM REVISITED” ERIN HIGGINS, MD, AND CHERYL B. IGLESIA, MD (AUGUST 2017) Pelvic examination is essential to clinical care I have contemplated the issue of the routine screening pelvic exam now for several years.
https://www.mdedge.com/familymedicine/article/134754/gynecologic-cancer/video-when-early-stage-vulvar-cancer-recurs
Oncology Practice; Kari Oakes
Mar 30th, 2017 - NATIONAL HARBOR, MD – Cancer of the vulva is becoming more common, and as incidence is rising, so are death rates from the relatively rare malignancy. A new examination of women with early-stage vulvar cancer showed that recurrence was common, and.
https://www.mdedge.com/hematology-oncology/article/109733/gynecologic-cancer/symptoms-linger-after-successful-gyn-cancer
Bruce Jancin
Jun 19th, 2016 - SAN DIEGO – Fully half of gynecologic cancer survivors who are done with treatment and cancer free nonetheless report having moderate to severe symptoms 2 and even 5 years after diagnosis, Dr. Michelle Rowland reported at the annual meeting of the.